THESE ARE THE 50 TOP STOCK PICKS THAT BILLIONAIRES LOVE
Bristol-Myers Squibb – Market Value: $139.6 Billion
As people stay in, the pharmaceutical industry is trailing far behind in recent times as trips to a doctor become infrequent. However, from the broader perspective, it still remains a lucrative deal. Blue Rock Advisors is one of the firms with this belief as it has bought a total of 126,737 shares, valued at $7.6 million, in Bristol-Myers Squibb.
The move comes on the heels of the hedge fund’s sudden interest to invest in healthcare, and they are not starting small! In one big swoop, Bristol-Myers Squibb’s shares now account for 6.6% of the total portfolio size for Blue Rock Advisors.
You must be logged in to post a comment Login